Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Schierle

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Expert Opinion on Therapeutic Patents|July 13, 2019
Therapeutic modulation of retinoid X receptors - SAR and therapeutic potential of RXR ligands and recent patentsSimone Schierle, Daniel Merk
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2018
Development of Nuclear Receptor ModulatorsSimone Schierle, Daniel Merk
Chemmedchem|October 25, 2018
Selective Optimization of Pranlukast to Farnesoid X Receptor ModulatorsSimone Schierle, Jurema Schmidt, Astrid Kaiser, et al.
Bioorganic & Medicinal Chemistry|July 21, 2018
Structural optimization and in vitro profiling of N-phenylbenzamide-based farnesoid X receptor antagonistsJurema Schmidt, Simone Schierle, Leonie Gellrich, et al.
Journal of Medicinal Chemistry|October 11, 2021
Development and Profiling of Inverse Agonist Tools for the Neuroprotective Transcription Factor Nurr1Daniel Zaienne, Sabine Willems, Simone Schierle, et al.
Chemmedchem|May 30, 2019
Computer-Assisted Selective Optimization of Side-Activities-from Cinalukast to a PPARα ModulatorJulius Pollinger, Simone Schierle, Sebastian Neumann, et al.
International Journal of Molecular Sciences|September 9, 2022
Activity Screening of Fatty Acid Mimetic Drugs Identified Nuclear Receptor AgonistsMoritz Helmstädter, Simone Schierle, Laura Isigkeit, et al.
Journal of Medicinal Chemistry|July 21, 2020
Design and Structural Optimization of Dual FXR/PPARδ ActivatorsSimone Schierle, Sebastian Neumann, Pascal Heitel, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
A New FXR Ligand Chemotype with Agonist/Antagonist SwitchMoritz Helmstädter, Jan Vietor, Jana Sommer, et al.
Chemmedchem|April 15, 2021
Development and in vitro Profiling of Dual FXR/LTA4H ModulatorsSimone Schierle, Steffen Brunst, Moritz Helmstädter, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Expert Opinion on Therapeutic Patents|July 13, 2019
Therapeutic modulation of retinoid X receptors - SAR and therapeutic potential of RXR ligands and recent patentsSimone Schierle, Daniel Merk
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2018
Development of Nuclear Receptor ModulatorsSimone Schierle, Daniel Merk
Chemmedchem|October 25, 2018
Selective Optimization of Pranlukast to Farnesoid X Receptor ModulatorsSimone Schierle, Jurema Schmidt, Astrid Kaiser, et al.
Bioorganic & Medicinal Chemistry|July 21, 2018
Structural optimization and in vitro profiling of N-phenylbenzamide-based farnesoid X receptor antagonistsJurema Schmidt, Simone Schierle, Leonie Gellrich, et al.
Journal of Medicinal Chemistry|October 11, 2021
Development and Profiling of Inverse Agonist Tools for the Neuroprotective Transcription Factor Nurr1Daniel Zaienne, Sabine Willems, Simone Schierle, et al.
Chemmedchem|May 30, 2019
Computer-Assisted Selective Optimization of Side-Activities-from Cinalukast to a PPARα ModulatorJulius Pollinger, Simone Schierle, Sebastian Neumann, et al.
International Journal of Molecular Sciences|September 9, 2022
Activity Screening of Fatty Acid Mimetic Drugs Identified Nuclear Receptor AgonistsMoritz Helmstädter, Simone Schierle, Laura Isigkeit, et al.
Journal of Medicinal Chemistry|July 21, 2020
Design and Structural Optimization of Dual FXR/PPARδ ActivatorsSimone Schierle, Sebastian Neumann, Pascal Heitel, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
A New FXR Ligand Chemotype with Agonist/Antagonist SwitchMoritz Helmstädter, Jan Vietor, Jana Sommer, et al.
Chemmedchem|April 15, 2021
Development and in vitro Profiling of Dual FXR/LTA4H ModulatorsSimone Schierle, Steffen Brunst, Moritz Helmstädter, et al.
Pageof 2